TerminatedNCT00181896

Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolarity

Medication studyAges 6–17United States

The study in practice

Understand this study

This study is for people with bipolarity. Listed age limits: 6 years to 17 years. Other eligibility criteria apply.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateJanuary 2005

Recruitment status: Terminated
Enrollment listed in the registry: 1
Sponsor: Massachusetts General Hospital
Sponsor type: Hospital / academic medical center
Study type: Drug
Intervention type: Drug
Study phase: Phase 4
Locations: United States
Age range: From 6 Years to 17 Years
Official registry ID: NCT00181896
Official title: Show the full official title
Open-Label Study of Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar and Bipolar Spectrum Disorder

Terminated

Cambridge

FAQ

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including bupropion SR.

Who can participate?

This study is for people with bipolarity. Listed age limits: 6 years to 17 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.